{
    "title": "3.1. Antenatal Clinic",
    "en": "3.1. Antenatal Clinic",
    "fr": "3.1. Consultation Prénatale (CPN)",
    "type": "object",
    "properties": {
        "antenatal_clinic_visit_1": {
            "line_number": "1",
            "fr": "Nouveaux cas SVSVisites CPN 1",
            "en": "Antenatal Clinic visit 1",
            "condition": "true"
        },
        "pregnant_women_less_than_20_yrs": {
            "line_number": "2",
            "fr": "Femmes enceintes < 20 Ans",
            "en": "Pregnant women less than 20 yrs",
            "condition": "true"
        },
        "antenatal_clinic_visit_2": {
            "line_number": "3",
            "fr": "Visites CPN 2",
            "en": "Antenatal Clinic visit 2",
            "condition": "true"
        },
        "antenatal_clinic_visit_3": {
            "line_number": "4",
            "fr": "Visites CPN 3",
            "en": "Antenatal Clinic visit 3",
            "condition": "true"
        },
        "antenatal_clinic_vist_4": {
            "line_number": "5",
            "fr": "Visites CPN 4",
            "en": "Antenatal Clinic vist 4",
            "condition": "true"
        },
        "pregnant_women_who_realised_the_antenatal_cininc_1st_term": {
            "line_number": "6",
            "fr": "Femmes enceinte ayant réalisé la CPN1 au 1er trimestre",
            "en": "Pregnant women who realised the Antenatal cininc 1st term",
            "condition": "true"
        },
        "pregnant_women_with_anc4_during_their_last_pregnancy": {
            "line_number": "7",
            "fr": "Femmes enceinte avec CPN 4 pendant leur dernière grossesse",
            "en": "Pregnant women with ANC4 during their last pregnancy",
            "condition": "true"
        },
        "pregnant_women_with_anc4_with_one_at_8th_or_9th_month": {
            "line_number": "8",
            "fr": "Femmes enceinte avec CPN 4 dont une au 8ème-9ème mois",
            "en": "Pregnant women with ANC4  with one at 8th or 9th month",
            "condition": "true"
        },
        "tested_pregnant_women_at_risk": {
            "line_number": "9",
            "fr": "Femmes enceinte à risque détectées",
            "en": "Tested Pregnant women at risk",
            "condition": "true"
        },
        "refered_pregant_women_at_risk_to_the_general_hospital": {
            "line_number": "10",
            "fr": "Femmes enceinte à risque référée vers l'HGR",
            "en": "Refered Pregant women at risk to the general hospital",
            "condition": "true"
        },
        "pregnant_women_under_20_yrs_refered": {
            "line_number": "11",
            "fr": "Femmes enceintes < 20 Ans référées",
            "en": "Pregnant women under 20 yrs refered",
            "condition": "true"
        },
        "iron_plus_folic_acid_1st_dose_received": {
            "line_number": "12",
            "fr": "Fer + Acide Folique 1ère dose reçue",
            "en": "Iron + folic acid 1st dose received",
            "condition": "true"
        },
        "iron_plus_folic_acid_2nd_dose_received": {
            "line_number": "13",
            "fr": "Fer + Acide Folique 2ème dose reçues",
            "en": "Iron + folic acid 2nd dose received",
            "condition": "true"
        },
        "iron_plus_folic_acid_3rd_dose_received": {
            "line_number": "14",
            "fr": "Fer + Acide Folique 3ème dose reçue",
            "en": "Iron + folic acid 3rd dose received",
            "condition": "true"
        },
        "sulfadox_plus_pyrimet_1st_dose_received": {
            "line_number": "15",
            "fr": "Sulfadox. + Pyrimét 1ère dose reçue",
            "en": "Sulfadox + Pyrimet 1st dose received",
            "condition": "true"
        },
        "sulfadox_plus_pyrimet_2nd_dose_received": {
            "line_number": "16",
            "fr": "Sulfadox. + Pyrimét 2ème dose reçues",
            "en": "Sulfadox + Pyrimet 2nd dose received",
            "condition": "true"
        },
        "sulfadox_plus_pyrimet_3rd_dose_received": {
            "line_number": "17",
            "fr": "Sulfadox. + Pyrimét 3ème dose reçue",
            "en": "Sulfadox + Pyrimet 3rd dose received",
            "condition": "true"
        },
        "completed_vaccinated_before_pregnancy": {
            "line_number": "18",
            "fr": "Complètement vaccinées avant grossesse",
            "en": "Completed vaccinated before pregnancy",
            "condition": "true"
        },
        "who_required_the_mild": {
            "line_number": "19",
            "fr": "Ayant acquis une MILD",
            "en": "Who required the MILD",
            "condition": "true"
        },
        "who_received_mebendazole_since_the_2nd_term": {
            "line_number": "20",
            "fr": "Ayant reçu le Mébendazole à partir du 2ème trimestre",
            "en": "Who received Mebendazole since the 2nd term",
            "condition": "true"
        },
        "target_population": {
            "line_number": "21",
            "line": "singlecell",
            "fr": "Population cible = fe du mois",
            "en": "target population= monthly woman",
            "condition": "true"
        },
        "anc_sessions": {
            "line_number": "22",
            "line": "singlecell",
            "fr": "Séances de CPN",
            "en": "ANC sessions",
            "condition": "true"
        },
        "used_rate_anc": {
            "line_number": "23",
            "line": "singlecell",
            "fr": "Taux d’utilisation CPN = CPN 1 AS (Nlles inscrites)x 100/ Pop femmes enceintes du mois",
            "en": "Used rate ANC= ANC 1 AS (new registered)X100/pop monthly pregnant women",
            "condition": "true"
        },
        "pregnacies_at_high_risk_detected": {
            "line_number": "24",
            "line": "singlecell",
            "fr": "Proportion de grossesses à haut risque détectées = Tot Grossesses à haut risque détectées x 100 / Total Nlles Inscrites",
            "en": "Pregnacies at high risk detected = total pregnancies at high risk detected X100/tota new registered",
            "condition": "true"
        },
        "pregnancies_at_high_risk_avarage_refered": {
            "line_number": "25",
            "line": "singlecell",
            "fr": "Propor)on de grossesses à haut risque référées = Tot Grossesses à haut risque référées x 100 / Total femmes à hauts risques détectées inscrites",
            "en": "Pregnancies at high risk avarage refered= total pregnanciesat high risk refered X100/total women at high risk detected registered",
            "condition": "true"
        },
        "average_of_women_who_received_at_least_the_sp2": {
            "line_number": "26",
            "line": "singlecell",
            "fr": "Proportion de fe ayant reçu au moins la SP 2 = Nombre de femmes enceintes ayant reçu au moins 2 Quantité de SPX100 / Fe ayant effectué la première visite prénatale",
            "en": "Average of women who received at least the SP2= number of pregnant women Who received at least 2 quantities of SPX100/woman who was visited for the 1st time at ANC",
            "condition": "true"
        },
        "average_of_pregnant_women_who_received_one_mild_at_anc": {
            "line_number": "27",
            "line": "singlecell",
            "fr": "Proportion des femmes enceintes ayant reçues une MILD à la CPN = femmes enceintes ayant acquis MILD X 100/ Total CPN1",
            "en": "Average of pregnant women who received one MILD at ANC= Pregnant woman who required a MILD X100/total ANC 1",
            "condition": "true"
        }
    },
    "definitions": {
        "columns": {
            "total": {
                "fr": "Total",
                "en": "Total",
                "title": "Total",
                "condition": "true"
            }
        }
    }
}